No Data
No Data
B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating
B.Riley Financial analyst Mayank Mamtani maintains $Altimmune(ALT.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 27.8% and a total average return of -16.5% over
These Are the Weight Loss Drug Stocks With the Most Upside - SA Sentiment Survey
This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment
Better GLP-1 Biotech Stock: Altimmune Vs. Viking Therapeutics
Study Links GLP-1 Drugs, Metformin to Lower Risk of Certain Cancers
A Harvard study shows that semaglutide is related to rare vision loss. Novo Nordisk (NVO.US) leads the weight loss drug concept stocks in decline.
A Harvard study shows that the weight loss drugs Ozempic and Wegovy from Novo Nordisk A/S may be associated with rare vision loss.
No Data
Chili Dog : So see how many